Targeting phenol-soluble modulin α3-driven M1 macrophage polarization and necroptosis mitigates MRSA infection in mice.

Summary

This mechanistic study shows that MRSA virulence factor PSMα3 drives M1 macrophage polarization and necroptosis via an ISGF3–necrosome axis downstream of FPR2. Pharmacologic inhibition of STAT1 with the approved drug fludarabine attenuated MRSA infection in murine sepsis and pneumonia models, positioning anti-virulence targeting as a translational strategy.

Key Findings

• PSMα3 promoted M1 macrophage polarization and necroptosis linked via ISGF3–necrosome interactions.
• Formyl peptide receptor 2 (FPR2) functioned as the key receptor for PSMα3-mediated effects.
• STAT1 inhibition with fludarabine mitigated MRSA infection in murine sepsis and pneumonia models.

Clinical Implications

Suggests a potential adjunctive, anti-virulence therapy for MRSA sepsis by inhibiting STAT1 signaling; supports future dose-finding and safety trials combining fludarabine with antibiotics.

Limitations

• Findings are preclinical; human immune context and dosing safety remain untested
• Fludarabine’s immunosuppressive risks may limit sepsis use without careful stratification

Future Directions

Evaluate STAT1-targeted anti-virulence therapy in larger animal models; define safety, pharmacodynamics, and synergy with antibiotics; explore biomarkers (e.g., PSMα3 activity) for patient selection.